Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (71-80 of 113) with videos related to

Pageof 12
Sort By:
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2010
Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancerDonal P McLornan, Helen L Barrett, Robert Cummins, et al.
The Journal of Pathology|August 2, 2024
Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patientsMohammadreza Azimi, Sanghee Cho, Emir Bozkurt, et al.
Cancer Immunology Research|May 20, 2016
Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant ChemotherapyPhilip D Dunne, Darragh G McArt, Paul G O'Reilly, et al.
Cell Death Discovery|September 15, 2017
IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancerRyan A Hutchinson, Helen G Coleman, Kathy Gately, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Multiplex analysis of colorectal cancer tissue describes the composition, cell biology and spatial effects of cell-in-cell events and identifies a T cell-dependent prognostic signatureEmir Bozkurt, Batuhan Kisakol, Mohammadreza Azimi, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Spatial Effects of Infiltrating T cells on Neighbouring Cancer Cells and Prognosis in Stage III CRC patientsMohammadreza Azimi, Sanghee Cho, Emir Bozkurt, et al.
EMBO Reports|February 4, 2020
A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosisLuke M Humphreys, Jennifer P Fox, Catherine A Higgins, et al.
Nature Communications|June 1, 2017
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classificationPhilip D Dunne, Matthew Alderdice, Paul G O'Reilly, et al.
Pageof 12

Showing results (71-80 of 113) with videos related to

Sort By:
Pageof 12
Cell Death & Disease|October 24, 2018
Cytoplasmic FLIP(S) and nuclear FLIP(L) mediate resistance of castrate-resistant prostate cancer to apoptosis induced by IAP antagonistsChristopher McCann, Nyree Crawford, Joanna Majkut, et al.
Molecular Cancer Therapeutics|October 27, 2011
A systems biology approach identifies SART1 as a novel determinant of both 5-fluorouracil and SN38 drug resistance in colorectal cancerWendy L Allen, Leanne Stevenson, Vicky M Coyle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 24, 2010
Prognostic significance of TRAIL signaling molecules in stage II and III colorectal cancerDonal P McLornan, Helen L Barrett, Robert Cummins, et al.
The Journal of Pathology|August 2, 2024
Spatial effects of infiltrating T cells on neighbouring cancer cells and prognosis in stage III CRC patientsMohammadreza Azimi, Sanghee Cho, Emir Bozkurt, et al.
Cancer Immunology Research|May 20, 2016
Immune-Derived PD-L1 Gene Expression Defines a Subgroup of Stage II/III Colorectal Cancer Patients with Favorable Prognosis Who May Be Harmed by Adjuvant ChemotherapyPhilip D Dunne, Darragh G McArt, Paul G O'Reilly, et al.
Cell Death Discovery|September 15, 2017
IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancerRyan A Hutchinson, Helen G Coleman, Kathy Gately, et al.
Biorxiv : the Preprint Server for Biology|August 12, 2025
Multiplex analysis of colorectal cancer tissue describes the composition, cell biology and spatial effects of cell-in-cell events and identifies a T cell-dependent prognostic signatureEmir Bozkurt, Batuhan Kisakol, Mohammadreza Azimi, et al.
Biorxiv : the Preprint Server for Biology|February 14, 2024
Spatial Effects of Infiltrating T cells on Neighbouring Cancer Cells and Prognosis in Stage III CRC patientsMohammadreza Azimi, Sanghee Cho, Emir Bozkurt, et al.
EMBO Reports|February 4, 2020
A revised model of TRAIL-R2 DISC assembly explains how FLIP(L) can inhibit or promote apoptosisLuke M Humphreys, Jennifer P Fox, Catherine A Higgins, et al.
Nature Communications|June 1, 2017
Cancer-cell intrinsic gene expression signatures overcome intratumoural heterogeneity bias in colorectal cancer patient classificationPhilip D Dunne, Matthew Alderdice, Paul G O'Reilly, et al.
Pageof 12